CSIMarket


Galectin Therapeutics Inc  (NASDAQ: GALT)
Other Ticker:  
 

Galectin Therapeutics Inc

GALT's Fundamental analysis








Galectin Therapeutics Inc's sales fell in the first quarter of 2025 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.5 %

Galectin Therapeutics Inc net loss decreased from $-11 millions, to $-10 millions in first quarter of 2025,

More on GALT's Growth


Galectin Therapeutics Inc
realized a net loss in trailing twelve months.

Galectin Therapeutics Inc realized cash reduction of $ -0.26 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.


More on GALT's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -1.81

Galectin Therapeutics Inc
realized net loss in trailing twelve months.

Galectin Therapeutics Inc realized cash outflow of $ -0.26per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.


More on GALT's Valuation

  Market Capitalization (Millions $) 83
  Shares Outstanding (Millions) 63
  Employees 20
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -42
  Cash Flow (TTM) (Millions $) -16
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) -1.81

  Market Capitalization (Millions $) 83
  Shares Outstanding (Millions) 63
  Employees 20
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -42
  Cash Flow (TTM) (Millions $) -16
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 0.08
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com